Wellesley, MA, United States of America

David Richard Willcox

USPTO Granted Patents = 3 

Average Co-Inventor Count = 8.0

ph-index = 3

Forward Citations = 15(Granted Patents)


Company Filing History:


Years Active: 2014-2018

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of David Richard Willcox

Introduction

David Richard Willcox is a notable inventor based in Wellesley, MA, who has made significant contributions to the field of pharmaceuticals. With a total of three patents to his name, Willcox has focused on developing solid forms of thiophosphoramidate nucleotide prodrugs, which have potential applications in treating various diseases and conditions.

Latest Patents

Willcox's latest patents include innovative formulations of 2'-C-methyluridine-5′-(O-phenyl-N-(S)-1-(isopropoxycarbonyl)ethyl)thiophosphoramidate. These patents detail the solid-state forms, such as crystalline forms, and pharmaceutical compositions that incorporate these solid forms. The methods described in his patents aim to treat or ameliorate diseases and conditions using these novel compounds, either alone or in combination with other agents.

Career Highlights

Throughout his career, David Richard Willcox has worked with prominent companies in the pharmaceutical industry, including Alios Biopharma, Inc. and Vertex Pharmaceuticals, Inc. His experience in these organizations has contributed to his expertise in drug development and innovation.

Collaborations

Willcox has collaborated with several professionals in his field, including Anuj K Kuldipkumar and Ales Medek. These collaborations have likely enhanced his research and development efforts, leading to his successful patent applications.

Conclusion

David Richard Willcox's work in developing solid forms of thiophosphoramidate nucleotide prodrugs showcases his innovative spirit and dedication to advancing pharmaceutical science. His contributions are poised to make a significant impact in the treatment of various diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…